136 related articles for article (PubMed ID: 36239795)
1. Guideline concordant therapy improves survival in high-grade endometrial cancer patients.
Scharl S; Sprötge T; Gerken M; Scharl A; Ortmann O; Kölbl O; Klinkhammer-Schalke M; Papathemelis T
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4761-4769. PubMed ID: 36239795
[TBL] [Abstract][Full Text] [Related]
2. Does post-operative radiochemotherapy improve survival in high-grade endometrial cancer patients? Results of a population-based cohort analysis of a cancer registry.
Scharl S; Papathemelis T; Kronberger K; Gerken M; Scharl A; Kölbl O; Klinkhammer-Schalke M
Arch Gynecol Obstet; 2018 May; 297(5):1245-1253. PubMed ID: 29417286
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Prognostic Factors and Adjuvant Radiotherapy on Survival in Patients with High-Grade Early-Stage Endometrial Cancer: A Retrospective Clinical Study.
Yilmaz E; Gurocak S; Melekoglu R; Koleli I; Faydali S; Temelli O; Yar T
Med Sci Monit; 2019 Apr; 25():2811-2818. PubMed ID: 30992424
[TBL] [Abstract][Full Text] [Related]
4. Improved survival endpoints with adjuvant radiation treatment in patients with high-risk early-stage endometrial carcinoma.
Elshaikh MA; Vance S; Suri JS; Mahan M; Munkarah A
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):351-6. PubMed ID: 24411608
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy for advanced endometrial cancer.
Galaal K; Al Moundhri M; Bryant A; Lopes AD; Lawrie TA
Cochrane Database Syst Rev; 2014 May; 2014(5):CD010681. PubMed ID: 24832785
[TBL] [Abstract][Full Text] [Related]
6. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
7. Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival--a retrospective multi-centre cohort study.
Schwentner L; Wolters R; Koretz K; Wischnewsky MB; Kreienberg R; Rottscholl R; Wöckel A
Breast Cancer Res Treat; 2012 Apr; 132(3):1073-80. PubMed ID: 22205141
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant radiotherapy for stage I endometrial cancer.
Kong A; Johnson N; Kitchener HC; Lawrie TA
Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003916. PubMed ID: 22513918
[TBL] [Abstract][Full Text] [Related]
9. Impact of adjuvant radiotherapy on the survival of women with optimally resected stage III endometrial cancer in the era of modern radiotherapy: a retrospective study.
Chen JL; Huang YS; Huang CY; Hsu CY; Lan KH; Cheng WF; Kuo SH
Radiat Oncol; 2020 Apr; 15(1):72. PubMed ID: 32252781
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing treatment decision and guideline conformity in high-grade endometrial cancer patients: a population-based study.
Scharl S; Sprötge T; Gerken M; Scharl A; Ignatov A; Inwald EC; Ortmann O; Kölbl O; Klinkhammer-Schalke M; Papathemelis T
Arch Gynecol Obstet; 2022 Jan; 305(1):203-213. PubMed ID: 34223974
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
Kuku S; Williams M; McCormack M
Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant radiotherapy for stage I endometrial cancer.
Kong A; Johnson N; Kitchener HC; Lawrie TA
Cochrane Database Syst Rev; 2012 Mar; (3):CD003916. PubMed ID: 22419290
[TBL] [Abstract][Full Text] [Related]
13. A Multi-Institutional Analysis of Adjuvant Chemotherapy and Radiation Sequence in Women With Stage IIIC Endometrial Cancer.
Hathout L; Wang Y; Wang Q; Vergalasova I; Elshaikh MA; Dimitrova I; Damast S; Li JY; Fields EC; Beriwal S; Keller A; Kidd EA; Usoz M; Jolly S; Jaworski E; Leung EW; Donovan E; Taunk NK; Chino J; Natesan D; Russo AL; Lea JS; Albuquerque KV; Lee LJ
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1423-1431. PubMed ID: 33677053
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary study of sequential multi-modality adjuvant chemotherapy and radiation for advanced endometrial cancer].
Zhang G; Suo HY; Shen XY; Zhao LJ; Wang ZQ; Kong WM; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2019 Feb; 54(2):103-109. PubMed ID: 30803169
[No Abstract] [Full Text] [Related]
15. Guideline-concordant endometrial cancer treatment and survival in the Women's Health Initiative Life and Longevity After Cancer study.
Felix AS; McLaughlin EM; Caan BJ; Cohn DE; Anderson GL; Paskett ED
Int J Cancer; 2020 Jul; 147(2):404-412. PubMed ID: 31618444
[TBL] [Abstract][Full Text] [Related]
16. Postoperative Adjuvant Treatment in Women with Stage I Endometrial Cancer: A Retrospective Study.
Fu P; Sun H; Zhou T; Cui P; Wang S; Liu R
Int J Clin Pract; 2023; 2023():4007616. PubMed ID: 37035519
[TBL] [Abstract][Full Text] [Related]
17. [Using Immunohistochemical Markers and Clinicopathological Factors to Predict the Prognostic Survival of Different Types of Endometrial Cancer Recurrence].
Huang Z; Jiang P; Jia MZ; Li L; Deng Y; Lai L; Hu ZY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):489-496. PubMed ID: 34018370
[TBL] [Abstract][Full Text] [Related]
18. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
19. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G
Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
[TBL] [Abstract][Full Text] [Related]
20. The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance.
Ko EM; Walter P; Clark L; Jackson A; Franasiak J; Bolac C; Havrilesky L; Secord AA; Moore DT; Gehrig PA; Bae-Jump VL
Gynecol Oncol; 2014 Apr; 133(1):28-32. PubMed ID: 24680588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
